SEC Form 4 · accession 0001365618-16-000007

Anacor Pharmaceuticals, Inc. · ANAC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Table I — non-derivative securities

Table II — derivative securities

Explanation of responses

• F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Venrock Healthcare Capital Partners, L.P. ("VHCP"), VHCP Co-Investment Holdings, LLC ("VHCP Co-Invest"), Venrock Associates IV, L.P. ("VA4"), Venrock Partners, L.P. ("VP") and Venrock Entreprenerus Fund IV, L.P. ("VEF4") on March 16, 2016.
• F10The shares are held as follows: 49,679 shares held by VA4, 10,131 shares held by VP, 1,221 shares held by VEF4, 39,302 shares held by VHCP and 7,189 shares held by VHCP Co-Invest.
• F11The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.11 to $74.16, inclusive.
• F12The shares are held as follows: 49,587 shares held by VA4, 10,113 shares held by VP, 1,218 shares held by VEF4, 39,228 shares held by VHCP and 7,176 shares held by VHCP Co-Invest.
• F13The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.17 to $75.84, inclusive.
• F14The shares are held as follows: 46,436 shares held by VA4, 9,470 shares held by VP, 1,141 shares held by VEF4, 36,735 shares held by VHCP and 6,720 shares held by VHCP Co-Invest.
• F15The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.50, inclusive.
• F16The shares are held as follows: 44,649 shares held by VA4, 9,106 shares held by VP, 1,097 shares held by VEF4, 35,321 shares held by VHCP and 6,461 shares held by VHCP Co-Invest.
• F17The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.39 to $71.41, inclusive.
• F18The shares are held as follows: 44,464 shares held by VA4, 9,068 shares held by VP, 1,092 shares held by VEF4, 35,175 shares held by VHCP and 6,435 shares held by VHCP Co-Invest.
• F19The reporting person is a member of VR Management, LLC (the "Management Company"). Under an agreement between the reporting person and the Management Company, the reporting person is deemed to hold an aggregate of 794 of the reported securities for the sole benefit of the Management Company (the "Management Company Shares"). The Management Company may be deemed the indirect beneficial owner of the Management Company Shares, and the reporting person may be deemed the indirect beneficial owner of the Management Company Shares through his interest in the Management Company. The reporting person disclaims beneficial ownership of the Management Company Shares except to the extent of his indirect pecuniary interest therein.
• F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) - (18) to this Form 4.
• F3The shares are held as follows: 102,931 shares held by VA4, 20,991 shares held by VP, 2,529 shares held by VEF4, 81,429 shares held by VHCP and 14,895 shares held by VHCP Co-Invest.
• F4Venrock Management IV, LLC ("VM4"), Venrock Partners Management, LLC ("VPM") and VEF Management IV, LLC ("VEFM4") are the sole general partners of VA4, VP and VEF4, respectively, and may be deemed to beneficially own these shares. VHCP Management, LLC ("VHCP Management") is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. Anders Hove is a member of VM4, VPM and VEFM4 and a managing member of VHCP Management. Dr. Hove expressly disclaims beneficial ownership over all shares held by VA4, VP, VEF4, VHCP, VHCP Co-Invest, VM4, VPM, VEFM4 and VHCP Management except to the extent of his indirect pecuniary interest therein.
• F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.00 to $71.99, inclusive.
• F6The shares are held as follows: 56,736 shares held by VA4, 11,570 shares held by VP, 1,394 shares held by VEF4, 44,884 shares held by VHCP and 8,210 shares held by VHCP Co-Invest.
• F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.00 to $72.96, inclusive.
• F8The shares are held as follows: 50,729 shares held by VA4, 10,345 shares held by VP, 1,247 shares held by VEF4, 40,132 shares held by VHCP and 7,341 shares held by VHCP Co-Invest.
• F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.03 to $73.88, inclusive.